Skip to content

PressReach

SEARCH icon
  • Investing
  • Featured
  • Market
  • Biotech
  • Oil & Gas
  • Mining
  • Gaming
  • Tech
  • Crypto
  • More
    • Health
    • Entertainment
    • Real Estate
    • Cannabis
    • ESG
    • Financial
    • Food & Beverage
    • Industrials
    • Travel & Hospitality
    • Trading Tips
    • Investing Videos
Search

SEARCH FOR AN ARTICLE

  • Investing
  • Featured
  • Market
  • Biotech
  • Oil & Gas
  • Mining
  • Gaming
  • Tech
  • Crypto
  • More
    • Health
    • Entertainment
    • Real Estate
    • Cannabis
    • ESG
    • Financial
    • Food & Beverage
    • Industrials
    • Travel & Hospitality
    • Trading Tips
    • Investing Videos

PressReach

icon

      HomeBiotech

      Biotech

      CureLab Veterinary’s ElenaVet™ Gene Therapy Delivers 90% Success in Pet-Dog Osteoarthritis Study
      Biotech

      CureLab Veterinary’s ElenaVet™ Gene Therapy Delivers 90% Success in Pet-Dog Osteoarthritis Study

      June 14, 2025
      DRI Healthcare Trust Comments on FDA Delay for KalVista Pharmaceuticals’ Sebetralstat PDUFA Goal Date Due to FDA Resourcing Constraints
      Biotech

      DRI Healthcare Trust Comments on FDA Delay for KalVista Pharmaceuticals’ Sebetralstat PDUFA Goal Date Due to FDA Resourcing Constraints

      June 14, 2025
      Keymed Biosciences Announces the Latest Clinical Trial Results of CM336 Published in the New England Journal of Medicine
      Biotech

      Keymed Biosciences Announces the Latest Clinical Trial Results of CM336 Published in the New England Journal of Medicine

      June 13, 2025
      Enliven Therapeutics Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants
      Biotech

      Enliven Therapeutics Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants

      June 13, 2025
      Fapon Biopharma to Showcase Differentiated Pipeline, Including Phase 1 Immunocytokine FP008, and Innovative Technology Platforms at BIO 2025
      Biotech

      Fapon Biopharma to Showcase Differentiated Pipeline, Including Phase 1 Immunocytokine FP008, and Innovative Technology Platforms at BIO 2025

      June 12, 2025
      Dizal Showcases Two First-in-Class Therapies in Hematologic Malignancies at EHA and ICML 2025
      Biotech

      Dizal Showcases Two First-in-Class Therapies in Hematologic Malignancies at EHA and ICML 2025

      June 12, 2025
      Ascend Completes GMP Certification for Quality Control Testing in Munich Facility
      Biotech

      Ascend Completes GMP Certification for Quality Control Testing in Munich Facility

      June 11, 2025
      Energenesis Biomedical to Unveil Promising Parkinson’s Disease Therapy, ENERGI-F705PD, at BIO International 2025
      Biotech

      Energenesis Biomedical to Unveil Promising Parkinson’s Disease Therapy, ENERGI-F705PD, at BIO International 2025

      June 11, 2025
      EQT Life Sciences Co-Leads USD 135 Million Series B Financing in SpliceBio
      Biotech

      EQT Life Sciences Co-Leads USD 135 Million Series B Financing in SpliceBio

      June 11, 2025
      Caliway to Present First Preclinical Data on CBL-514 for GLP-1 Weight Rebound Management at BIO 2025
      Biotech

      Caliway to Present First Preclinical Data on CBL-514 for GLP-1 Weight Rebound Management at BIO 2025

      June 10, 2025
      « 1 … 24 25 26 27 28 … 139 »

       

      LATEST NEWS

      • Health Sanofi Market Potential Boosted by Amvuttra Data

      PressReach

      All logos, trade names and/or trademarks, artwork and associated imagery are trademarks and/or copyright material of their respective owners.

      • Advertisers
      • Privacy Policy
      • Terms of Use
      • DMCA Policy
      • Disclaimer
      • Contact Us

      SUBSCRIBE

      To get email updates from PressReach.

      I want e-mail alerts, updates, and offers and agree to the PressReach privacy policy.

      Market Jar Media Inc. © 2026